CJC-1295 (DAC)

CJC-1295 (DAC) is a synthetic growth hormone–releasing hormone (GHRH) analog studied for its ability to stimulate sustained growth hormone release and downstream IGF-1 signaling.

For research and educational purposes only. Not for human consumption.

American-Owned • U.S.-Based Research Company
CJC-1295 (DAC) vial
Get Lucky with the Irish! Save 20% at checkout
Shop Sale →

What Is CJC-1295?

CJC-1295 is a long-acting analog of growth hormone–releasing hormone designed to bind to GHRH receptors in the pituitary gland. This interaction stimulates endogenous growth hormone secretion through physiological signaling pathways.

Growth Hormone & Endocrine Signaling

Research shows that CJC-1295 enhances both the amplitude and duration of growth hormone pulses, supporting investigation into anabolic signaling, metabolic regulation, and endocrine system dynamics.

IGF-1 Pathway Research

Increased growth hormone signaling initiated by CJC-1295 influences insulin-like growth factor 1 (IGF-1), a critical mediator of tissue growth, repair, and metabolic processes.

Why Researchers Study CJC-1295

  • Endogenous growth hormone stimulation
  • IGF-1 mediated tissue and metabolic pathways
  • Endocrine system signaling dynamics
  • Recovery and regenerative research models
  • Long-acting GHRH activity

Format & Storage

  • Lyophilized powder
  • Common vial sizes used in research: 2 mg
  • Store in a cool, dry environment prior to reconstitution
  • Refrigerate after reconstitution

Ready to Submit?

Review everything on the checkout page and submit your request. We will email your invoice.

Go to Checkout